Applause for making ithers aware of a growing product line. Especially one that has yet to prove itself. Not many have the patience. The best DD is right in their own filings. For now its close to 30M shares a quarter.
And somehow this still manages to hold support. And is maintaining a decent trend.
Yes, Innovus' marketing team continues to expand. Would like to hear more how their team is doing in Canada.
Really though, a small company like this can only make its mark by getting something that competes with bp. Fluticare may come on line and just pass gas like you said by the time it gets here.
As long as the revenue can overcome and eventually slow to stop the dilution, there's potential. For now, I'm willing to swing a few here and there along the way. This isn't one to go all in on for sure, but this character could get a decent fish on the line that changes the story.
News 
Market Data 
Discover 
